← All stocks

Encompass Health Corp

EHC Net selling
CIK 0000785161 #861 in the set updated 17 Sep 2026
Bought (120 mo)
$10.97M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$100.03M
$0.00 on a plan · $46.69M straight out of an exercise
Sold at will
$53.35M
28 of 55 sales
Net
−$89.07M
−$42.38M against sales at will

By person

28 insiders · 78 transactions
29.4×

Mark J. Tarr holds 29.4 times base salary in stock. $32.43M of shares against $1.10M in salary for 2025.

Salary from the company's own proxy. The shares are what Mark J. Tarr last reported holding, valued at $121.09, the price Encompass Health Common Stock was last bought or sold at on the open market here, on 31 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Tarr Mark J
President & CEO
$250.32K (1)
$69.35M (21)
−$69.10M
267,814
0.2715%
$32.43M
+9.4%
COLTHARP DOUGLAS E
EVP & Chief Financial Officer
$252.45K (1)
$14.98M (12) scheduled
−$14.73M
77,988
0.0791%
$9.44M
Anthony April Kaye Bullock
CEO & President, Home Health
$9.91M (8)
+$9.91M
724,111
0.7340%
$87.68M
Levy Cheryl B.
Chief Human Resources Officer
$4.21M (2)
−$4.21M
41,732
0.0423%
$5.05M
−51.8%
Darby John Patrick
EVP, Gen Counsel & Secretary
$4.08M (4) scheduled
−$4.08M
75,041
0.0761%
$9.09M
+394.2%
Price Andrew L
Chief Accounting Officer
$2.58M (4)
−$2.58M
69,483
0.0704%
$8.41M
+7.7%
Charbonneau Elissa Joy
Chief Medical Officer
$2.43M (4)
−$2.43M
17,644
0.0179%
$2.14M
+158.1%
Fay Edmund
Sr. Vice Pres. and Treasurer
$1.28M (1)
−$1.28M
86,325
0.0875%
$10.45M
+13.3%
Jacobsmeyer Barbara Ann
President & CEO, HHH
$518.22K (3)
−$518.22K
59,539
0.0604%
$7.21M
+211.1%
Tuer Patrick William
EVP, Chief Operating Officer
$499.14K (3)
−$499.14K
24,755
0.0251%
$3.00M
+78.3%
CARMICHAEL GREG D
Director
$267.51K (2)
+$267.51K
20,349
0.0206%
$2.46M
+1,288%
HIGDON LEO I JR
Director
$122.91K (2)
+$122.91K
80,391
0.0815%
$9.73M
+34.3%
CORRELL DONALD L
Director
$118.08K (1)
−$118.08K
99,938
0.1013%
$12.10M
+30.4%
CURL YVONNE M
Director
$80.55K (2)
+$80.55K
78,458
0.0795%
$9.50M
+34.3%
O'Connor Kevin J.
Director
$66.48K (1)
+$66.48K
11,582
0.0117%
$1.40M
+2,226%
Williams Terrance
Director
$20.04K (1)
+$20.04K
16,859
0.0171%
$2.04M
+1,050%
GRINNEY JAY
Pres & Chief Executive Officer
1,231,767
1.25%
$149.15M
−1.1%
CHIDSEY JOHN
Director
162,826
0.1650%
$19.72M
+34.4%
SHAW L EDWARD JR
Director
99,385
0.1007%
$12.03M
+25.2%
ELSON CHARLES M
Director
82,981
0.0841%
$10.05M
+28.8%
MAUPIN JOHN E JR D D S
Director
81,262
0.0824%
$9.84M
+30.0%
KATZ LESLYE G
Director
49,643
0.0503%
$6.01M
+105.7%
HERMAN JOAN E
Director
49,643
0.0503%
$6.01M
+105.7%
SCHLICHTING NANCY M
Director
22,972
0.0233%
$2.78M
+810.5%
Reidy Christopher R
Director
17,777
0.0180%
$2.15M
+1,977%
Maryland Patricia Anne
Director
14,764
0.0150%
$1.79M
+907.1%
Christie Edward M III
Director
9,345
0.0095%
$1.13M
Hayes Cain A
Director
2,096
0.0021%
$253.80K
Insider
Date
Role
Action
Shares
Price
Amount
Darby John Patrick
31 Aug 2026
EVP, Gen Counsel & Secretary
Sold after exercise
4,858
$121.09
$588.26K
COLTHARP DOUGLAS E
15 May 2026
EVP & Chief Financial Officer
Sold after exercise
1
$107.28
$107.28
COLTHARP DOUGLAS E
15 May 2026
EVP & Chief Financial Officer
Sold after exercise
27,693
$106.83
$2.96M
Tarr Mark J
20 May 2025
President & CEO
Sold after exercise
118,290
$121.53
$14.38M
Tarr Mark J
20 May 2025
President & CEO
Sold after exercise
94
$120.94
$11.37K
COLTHARP DOUGLAS E
29 Apr 2025
EVP & Chief Financial Officer
Sold after exercise
3,934
$116.36
$457.76K
COLTHARP DOUGLAS E
29 Apr 2025
EVP & Chief Financial Officer
Sold after exercise
13,402
$115.51
$1.55M
COLTHARP DOUGLAS E
29 Apr 2025
EVP & Chief Financial Officer
Sold after exercise
26,239
$114.78
$3.01M
Darby John Patrick
29 Apr 2025
EVP, Gen Counsel & Secretary
Sold after exercise
10,000
$114.79
$1.15M
COLTHARP DOUGLAS E
13 Aug 2024
EVP & Chief Financial Officer
Sold after exercise
98
$87.03
$8.53K
COLTHARP DOUGLAS E
13 Aug 2024
EVP & Chief Financial Officer
Sold after exercise
12,162
$86.33
$1.05M
Darby John Patrick
6 May 2024
EVP, Gen Counsel & Secretary
Sold after exercise
14,543
$83.94
$1.22M
Tarr Mark J
30 Apr 2024
President & CEO
Sold after exercise
44,976
$83.27
$3.75M
COLTHARP DOUGLAS E
13 Nov 2023
EVP & Chief Financial Officer
Sold after exercise
11,215
$63.39
$710.92K
Tarr Mark J
16 Aug 2023
President & CEO
Sold after exercise
25,330
$71.06
$1.80M
COLTHARP DOUGLAS E
10 Feb 2023
EVP & Chief Financial Officer
Sold after exercise
17,895
$60.78
$1.09M
Tarr Mark J
17 Aug 2022
President & CEO
Sold after exercise
20,449
$53.25
$1.09M
COLTHARP DOUGLAS E
28 May 2020
EVP & Chief Financial Officer
Sold after exercise
490
$76.15
$37.31K
COLTHARP DOUGLAS E
28 May 2020
EVP & Chief Financial Officer
Sold after exercise
23,011
$75.73
$1.74M
Tarr Mark J
14 May 2020
President & CEO
Sold after exercise
26,132
$61.92
$1.62M
Tarr Mark J
1 May 2019
President & CEO
Sold after exercise
23,943
$63.23
$1.51M
Tarr Mark J
1 May 2019
President & CEO
Sold after exercise
43,439
$63.74
$2.77M
Jacobsmeyer Barbara Ann
2 May 2018
President, Inpatient Hospitals
Sold after exercise
3,897
$62.51
$243.60K
Tarr Mark J
1 May 2018
President & CEO
Sold after exercise
16,575
$61.32
$1.02M
Tarr Mark J
1 May 2018
President & CEO
Sold after exercise
16,525
$60.60
$1.00M
Tarr Mark J
7 Aug 2017
President & CEO
Sold after exercise
22,625
$43.00
$972.88K
Tarr Mark J
3 Aug 2017
President & CEO
Sold after exercise
22,625
$42.55
$962.69K

What was left out

Form 4 filings counted 880
Amendments (4/A) skipped 10
Filings about a different issuer 1
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 27
Sales at will 28
Transactions with no price 0
Shares from compensation/vesting 4,335,517
Sales filed before the plan box existed 8
History held since 19 Oct 2016